[ XXXX after lung transplantation: a case report and literature review].

@entity1 @entity1030 @entity2 @entity900 @entity2879 @entity2416 @entity2098 @entity358 @entity618 @entity153 @entity3 @entity1140 @entity230 @entity151
BACKGROUND AND OBJECTIVE: Lung transplantation is an efficient therapeutic option for @entity1 with end-stage @entity358 , but less is known about @entity2 after lung transplantation. The aim of this study is to improve the awareness, diagnosis and treatment of @entity153 after lung transplantation with a case report and related literatures. METHODS: We reported a 65-year-old male with @entity2416 ( @entity2416 ) who underwent right lung transplantation under extracorporeal membrane oxygenation (ECMO) support in May 2007 in our hospital. The @entity1 recovered smoothly and discharged from the hospital 46 days after the procedure with regular follow-up. Immunosuppression therapy was triple drug maintenance regimen including @entity1140 (Tac), @entity618 ( @entity2098 ) and @entity230 . RESULTS: @entity151 in the left lung with multiple osseous @entity3 was found 13 months after the lung transplantation. Symptoms were relieved a bit by administering chemotherapeutics ( @entity2879 and @entity900 ) for 4 cycles. However, the @entity1 was succumbed to his illness within 11 months after the diagnosis of @entity2 . CONCLUSIONS: @entity2 after lung transplantation has been suggested as one of causes of late mortality with the risk factors such as @entity1030 ( @entity1030 ), @entity2416 , cigarette smoking history and immunosuppression etc. Early diagnosis and treatment are very important to improve the prognosis.
